Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Purple Biotech (PPBT) Return on Assets (2016 - 2025)

Purple Biotech has reported Return on Assets over the past 5 years, most recently at 0.0% for Q4 2022.

  • Quarterly Return on Assets changed 0.0% to 0.0% in Q4 2022 from the year-ago period, while the trailing twelve-month figure was 0.0% through Dec 2022, changed 0.0% year-over-year, with the annual reading at 0.0% for FY2022, 0.0% changed from the prior year.
  • Return on Assets was 0.0% for Q4 2022 at Purple Biotech, down from 0.0% in the prior quarter.
  • Over five years, Return on Assets peaked at 0.01% in Q2 2019 and troughed at 0.0% in Q2 2021.
  • The 5-year median for Return on Assets is 0.0% (2020), against an average of 0.0%.
  • The largest YoY upside for Return on Assets was 0bps in 2019 against a maximum downside of 0bps in 2019.
  • A 5-year view of Return on Assets shows it stood at 0.01% in 2018, then dropped by -24bps to 0.0% in 2019, then crashed by -90bps to 0.0% in 2020, then tumbled by -78bps to 0.0% in 2021, then soared by 1374bps to 0.0% in 2022.
  • Per Business Quant, the three most recent readings for PPBT's Return on Assets are 0.0% (Q4 2022), 0.0% (Q3 2022), and 0.0% (Q2 2022).